Table 2.

Number of genes with differential exon usage in genes with higher, lower, and similar expression in the three clinical subtypes compared to NBS.

	Genes with +1 Exons	Genes with −1 Exons	Total genes with DEU	Unspliced genes	Tot genes
log 2 FC >1 tumor vs NBS
ER+ HER2−	239	331	526	1,025	1,551
ER− HER2−	254	444	664	1,744	2,408
HER2+	254	427	624	1,374	1,998
log 2 FC < −1 tumor vs NBS
ER+ HER2−	146	217	333	818	1,151
ER− HER2−	199	192	362	1,004	1,366
HER2+	215	233	411	1,012	1,423
1 > log 2 FC > −1 tumor vs NBS
ER+ HER2−	1,443	1,515	2712	6,289	9,001
ER− HER2−	1,231	1,074	2135	5,511	7,646
HER2+	1,232	1,504	2503	5,684	8,187